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Abstract
Background: Unlike Caucasian populations, genetic factors contributing to the risk of type 2 diabetes mellitus (T2DM) are
not well studied in Asian populations. In light of this, and the fact that copy number variation (CNV) is emerging as a new
way to understand human genomic variation, the objective of this study was to identify type 2 diabetes–associated CNV in a
Korean cohort.
Methodology/Principal Findings: Using the Illumina HumanHap300 BeadChip (317,503 markers), genome-wide
genotyping was performed to obtain signal and allelic intensities from 275 patients with type 2 diabetes mellitus
(T2DM) and 496 nondiabetic subjects (Total n=771). To increase the sensitivity of CNV identification, we incorporated
multiple factors using PennCNV, a program that is based on the hidden Markov model (HMM). To assess the genetic effect
of CNV on T2DM, a multivariate logistic regression model controlling for age and gender was used. We identified a total of
7,478 CNVs (average of 9.7 CNVs per individual) and 2,554 CNV regions (CNVRs; 164 common CNVRs for frequency.1%) in
this study. Although we failed to demonstrate robust associations between CNVs and the risk of T2DM, our results revealed
a putative association between several CNVRs including chr15:45994758–45999227 (P=8.6E-04, P
corr=0.01) and the risk of
T2DM. The identified CNVs in this study were validated using overlapping analysis with the Database of Genomic Variants
(DGV; 71.7% overlap), and quantitative PCR (qPCR). The identified variations, which encompassed functional genes, were
significantly enriched in the cellular part, in the membrane-bound organelle, in the development process, in cell
communication, in signal transduction, and in biological regulation.
Conclusion/Significance: We expect that the methods and findings in this study will contribute in particular to genome
studies of Asian populations.
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Introduction
Type 2 diabetes mellitus (T2DM) is a serious metabolic disorder
that is characterized by insulin resistance and hyperglycemia. This
disease affects more than 170 million people worldwide, and is
therefore a major health problem [1]. Since T2DM prevalence is
higher in certain populations as suggested in twin and familial
studies, scientists suspect that genetic factors play a significant role
in the development of the disease [2]. The family aggregation
analysis has proved to be a useful tool for genetic studies and to
investigate predisposing factors of T2DM. Generally, the risk of
developing T2DM is known to be approximately 3–4 times higher
in the offspring of those with T2DM than in the offspring of those
without a family history of diabetes. The lifetime risk of developing
T2DM showed different ratios between offspring of one diabetic
parent (40%) and of two diabetic parents (70%) to the risk of the
disease [3,4]. In order to identify genetic loci associated with
T2DM, linkage, candidate, meta, and genome-wide association
study (GWAS) analyses have been widely performed for various
populations [5]. Among them, GWAS, which has allowed large-
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19091scale genotyping of hundreds of thousands of SNPs, is known as a
powerful tool for scanning the disease-susceptible region at the
whole-genome level [5]. Recently, the great development in
microarray technology has increased the number of identified
T2DM-susceptible gene loci using GWAS. To date, 25 common
variations have been reported to be associated with T2DM
through GWAS [6]. Compared to the abundant results of SNP
GWAS, the few CNV GWAS’s have been performed only in
Caucasians, and none of the reports provided evidence of
association with T2DM [7].
Ever since the duplication of the Bar gene and its contribution to
the size of the Bar eye were identified in Drosophila melanogaster 70
years ago [8], large-scale genomic variations have usually been
investigated using a microscope. In the past five years, compre-
hensive genomic variations, which cannot be visualized by
microscope, have been revealed using high-density microarray
and next-generation sequencing (NGS) platforms [9,10]. CNV can
contribute to disease susceptibility by influencing the gene
expression level [11]. CNV has been revealed to be associated
with complex human diseases including autism, inflammatory
autoimmune disorders, lung cancer, osteoporosis, subarachnoid
aneurysmal hemorrhage, sporadic amyotrophic lateral sclerosis,
avellino corneal dystrophy, and schizophrenia [12,13,14,15,
16,17,18,19,20,21]. Recent studies have focused on how CNV
in the human genome affects various inherited phenotypes,
including disease susceptibility [22,23]. Although the contribution
of CNVs to various complex human diseases has been verified,
studies on the association between the risk of T2DM and common
CNVR in humans at the genome-wide level are still needed [7].
To identify disease-susceptible loci and putative CNV,
PennCNV was performed using normalized signal intensity (log
R ratio: LRR) and allelic intensity (B allele frequency: BAF)
[17,24,25]. In addition, we speculate that the common CNVR is
more suitable for use in investigating the risk factors of complex
human diseases [14]. Therefore, this study used common CNVRs
(CNV freq..1%) that were obtained after samples with low
quality were filtered following a strict criteria.
The current study demonstrates genome-wide individual CNVs
identified using LRR and BAF, aggregated common CNVRs from
identified individual CNVs, and results from a genome-wide
association study with the risk of T2DM in a Korean population
using a logistic regression model controlling for age and gender as
covariates. We demonstrate our findings for three putative T2DM
risk CNVRs through GWAS and their expected biological
function.
Materials and Methods
Subjects and whole-genome SNP genotyping
A total of 275 unrelated patients with type 2 diabetes and 496
unrelated nondiabetic control subjects were recruited for this
study. Diabetes was diagnosed based on the guidelines of the
American Diabetes Association (ADA; 1997). Subjects with
positive GAD antibodies were excluded. All subjects enrolled in
this study were of Korean ethnicity. The study protocol was
approved by the Institutional Review Board of the Clinical
Research Institute at Korea National Institute of Health. Written
informed consent was obtained from all subjects before drawing
blood. Genome-wide SNP genotyping was performed using the
Illumina HumanHap300 BeadChip containing 317,503 markers
(Illumina, Inc., San Diego, CA, USA). Approximately 750 ng of
genomic DNA extracted from the blood of each individual was
used to genotype each sample. The assay procedure has been
described in our previous study [12]. The overall SNP genotyping
call rate of 99.91% in the current study indicated a high-quality
data set. Power calculation of this GWAS was estimated by the
Figure 1. Copy number variation validation by qPCR around rs682567 within chr15:45994758–45999227. (A) Genoplot image of the
identified deletions (marker name: rs682567). Genoplot image represents allelic intensity (X-axis) and signal intensity (Y-axis) of all samples. Two types
of copy numbers are depicted as 26and 16. Individuals having hemizygous deletions (copy number: 16) are clustered as two distinct groups (color:
yellow). Samples having null copy numbers are displayed with a black dot at the bottom. (B) Validation by qPCR around the rs682567 within chr15:
45994758–45999227. The value of the X-axis (expected copy number) is estimated by the Illumina Genoplot image analysis. The Y-axis indicates the
determined copy number by qPCR. The copy number value estimated through visual examination is matched with the quantitative measurement
value by qPCR.
doi:10.1371/journal.pone.0019091.g001
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QpowR.html) using the R package. The power in this study was
at 0.82 when sample size (n=720), number of markers
(n=317,000), and default conditions were input into the Power
calculator v1.0 of QpowR by parameters. The population
admixture analysis was performed by the PCA analysis function
in Golden HelixTree software (Golden Helix, Inc. Bozeman, MT,
USA; http://www.goldenhelix.com) using ancestry informative
markers (AIMs; n=2,621). In order to compare the distribution
from other populations, we used the genotypes from Japanese and
Chinese cohorts. Figure S1 indicates that our GWAS samples
showed homogeneity. Principal component analysis did not reveal
any population stratification or population outliers (Figure S1).
Identification of individual copy number variation
The signal intensity (LRR) and allelic intensity (BAF) ratios of all
samples were exported using the Illumina BeadStudio software.
Samples that did not satisfy the following criteria were excluded
from the study: (i) call rate .99.0%; (ii) number of identified
CNVs ,100; and (iii) standard deviation of LRR ,0.24, since
samples with LRR SDs .0.24 are likely to have a low quality,
resulting in a false positive CNV [26]. To identify individual
CNVs, we incorporated multiple factors including log R ratio, B
allele frequency, marker distance, and population frequency of the
B allele using PennCNV [25,27].
Visual examination analysis and real-time quantitative
PCR for CNV validation
The genoplot image in Figure 1a can be beneficial in estimating
copy number status of each subject. The image represents signal
intensity (Y-axis) and allelic intensity (X-axis) for all subjects at one
marker. Our previously reported result showed normal and
abnormal genoplot images of whether the marker was located
within the CNV or not [8]. If the marker was located within the
CNV, six distinct cluster can be observed (CNV genotypes: A/A,
A/B, B/B, A/-, B/-, and -/-). Two yellow-colored clusters in
Figure 1a indicate subjects having a 16 copy number (CNV
genotype: A/- and B/-, respectively). However, since this is an
indirect estimation method by visual examination, we performed a
direct quantitative PCR in selected subjects using the estimated
copy number from the visual examination. In order to run qPCR,
we designed a specific amplification primer set (forward primer
sequence: 59-GAAGAGGAGCAAGGCAAGGT-39; reverse
primer sequence: 59-AGAATGACTCCTGTGGTCTTCACTA-
39) and TaqMan probe (59-TACTGTGCTTACCTTCAAGAC-
TAAC-39) to validate the existence of the CNV within
chr15:45994758–45999227, which is commonly associated with
the risk of T2DM. Copy number determination analysis was
performed using the ABI Prism 7900 sequence detection system.
The RNaseP gene was co-amplified with the marker, which was
then used as an internal standard. Amplification reactions (10 ul)
Table 1. Summary of common CNVRs (Freq..5%).
CNV region
Length
(kb)
No.
of CNVs
CNV
Frequency
*
No.
of genes Gene
Overlapping
with DGV
**
chr18:64835114–64906488 71.4 169 0.219 1 CCDC102B YES
chr19:20368239–20528316 160.1 145 0.188 2 ZNF737,ZNF826 YES
chr4:162050188–162154792 104.6 137 0.178 0 YES
chr14:43524894–43690442 165.5 99 0.128 0 YES
chr18:3559620–3561217 1.6 88 0.114 1 DLGAP1 YES
chr8:4905758–5947152 1041.4 84 0.109 0 YES
chr15:45994758–45999227 4.5 79 0.102 0 YES
chr11:5828407–5911385 83.0 66 0.086 2 OR52E4,OR52E8 YES
chr21:16693940–16716168 22.2 57 0.074 1 C21orf34 YES
chr8:15447669–15471819 24.2 54 0.070 1 TUSC3 YES
chr22:20352005–21702142 1350.1 52 0.067 13 GGTLC2,LOC648691,LOC96610,
MAPK1,POM121L1P,PPIL2,PPM1F,
PRAME,TOP3B,VPREB1,YPEL1,
ZNF280A,ZNF280B
YES
chr4:153203765–153212191 8.4 50 0.065 0 YES
chr3:65166887–65187636 20.7 48 0.062 0 YES
chr6:31463297–31572718 109.4 48 0.062 3 HCG26,HCP5,MICA YES
chr12:130289496–130380887 91.4 47 0.061 0 YES
chr9:11743695–12194748 451.1 46 0.060 0 YES
chr10:90934639–90935788 1.1 44 0.057 0 YES
chr12:7861988–8017012 155.0 44 0.057 2 SLC2A14,SLC2A3 YES
chr8:145028388–145358471 330.1 42 0.054 13 C8orf30A,CYC1,EXOSC4,GPAA1,
GRINA,HEATR7A,KIAA1875,MAF1,
OPLAH,PARP10,PLEC1,SHARPIN,SPATC1
YES
chr5:32137157–32205304 68.1 40 0.052 2 GOLPH3,PDZD2 YES
chr5:41251228–41270765 19.5 40 0.052 1 C6 YES
*The CNV frequencies were obtained by number of total identified CNVs/number of total subjects.
**Database of genomic variants (http://projects.tcag.ca/variation).
doi:10.1371/journal.pone.0019091.t001
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Universal Master Mix buffer (Applied Biosystems, Foster City,
CA, USA), 900 nM of each primer, and 250 nM of each
fluorogenic probe. Thermal cycling was initiated with 2 min
incubation at 50uC, followed by a 10 min incubation at 95uC, and
40 cycles of 95uC 15 sec, 60uC 1 min. The first three replicate
reactions were performed for similar primer pairs, and each copy
number for an individual was calculated by Copy Caller v1.0
(Applied Biosystems) using the comparative CT method.
Logistic regression analysis and gene ontology analysis
CNVR is defined by merging overlapping CNVs. An input
matrix is contained the status of samples in the each CNVR built
from them. We generated input data for both loss (homozygous
deletion=06; hemizygous deletion=16; normal copy num-
ber=26) and gain (normal copy number=26; duplication=36;
amplification $46). After constructing CNVRs from identified
CNVs, the number of CNVs in the regions were counted in both
case and control groups. Logistic regression analyses controlling
for age (continuous value) and sex (male=0 or female=1) as
covariates were used to calculate the P-values for case–control
analysis. Multiple testing of CNVRs was carried out using the false
discovery rate (FDR) method (frequency.1%). As long as it is a
common multivariate logistic regression, this calculation can be
easily done with any statistical tool such as the R package or SAS.
Since there are many thousands of CNVRs, we built a java
application for this repetitive calculation. This application also
produces an input matrix from the CNV calls and the clinical
information sheet, builds and trims different types of CNVRs, and
calculates regression and FDR at a stroke. (The application will be
announced and further described in a separate article.) In order to
gain insights into the functional enrichment of CNVs, we
performed gene ontology (GO) analysis using GOstat (http://
gostat.wehi.edu.au) provided by Tim Beissbarth [28,29].
Results
In this study, we generated 7,478 individual CNVs and 2,554
CNVRs in a Korean population sample (n=771) using the
Illumina HumanHap300 BeadChip and PennCNV. The average
number of CNVs per sample was 9.7, with an average length of
79.0 kb and a median size of 26.7 kb (Table S1). A total of 21
common CNVRs (frequency.5%) containing 21 genes, together
with the rest of the regions, were found to overlap with previously
reported CNVs in the Database of Genomic Variants (DGV)
(Table 1). Furthermore, we were able to observe that 71.7% of the
CNVs identified in this study matched those found in the DGV
(Figure S2). However, all CNVs in the DGV overlapped with our
results below 30%. We speculate that our results can explain only
a small part of all human CNVs due to the sample size and ethnic
differences. The size distribution of CNVs identified in this study is
summarized in Figure S3, which shows that most were distributed
within a range of 1–50 kb.
To identify new genetic risk factors that may contribute to the
development of T2DM, we performed a genome-wide association
study (GWAS) of CNVs in a total of 771 Korean ethnic
individuals, including T2DM patients (n=275) and control
subjects (n=496). Logistic regression analyses controlling for age
and gender as covariates were performed to carry out the GWAS
of 164 common CNVRs (frequency.1%) with T2DM. Gene
ontology (GO) analysis can provide insights into the functional
enrichment of identified CNVs. After we extracted genes covering
the CNVs identified in this study, we performed GO analysis. As a
result, we found that genes significantly enriched in the identified
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PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e19091CNVs include cell part, organelle, development process, biological
regulation, and signal transduction (Table S2).
Three novel candidate T2DM loci, chr15:45994758–45999227
(15q21.1, P=8.6E-4, P
corr=0.01), chr22:20722473–21702142
(22q11.22, P=0.009, P
corr=0.06), and chr18:3559620–3561217
(18p11.31, P=0.01, P
corr=0.06), were found to be significantly
associated with the risk of T2DM in a Korean population (Table 2,
Figure 2). One CNVR (chr15:45994758–45999227) was associat-
ed with susceptibility to T2DM even after FDR corrections for
multiple testing (OR=2.6, 95% CI=1.5–4.5, P=0.01, Table 2).
Figure S4 shows the positional and probe information from the
DGV genome browser around 15q21.1 (chr15:45994758–
45999227). This target CNV covers three consecutive markers
(rs549368, rs682567, and rs2965306). Two nearby genes,
SEMA6D and SLC24A5, were distributed in 141.0 kb and
201.2 kb distances, respectively. Furthermore, two previously
reported CNVs (variation_10483 and variation_38328) on DGV
overlapped with the CNVs in this study. In order to validate
the quantitative change of copy number for the identified
T2DM-susceptible CNVR, we selected rs682567 within
chr15:45994758–45999227 and performed quantitative PCR
(qPCR) (Figure 1). Results of visualization from the genoplot
image showed a copy number change between patients and
controls, indicating that chr15:45994758–45999227 might be a
T2DM-susceptible region.
Discussion
Type 2 diabetes mellitus (T2DM) is a metabolic disorder
characterized by high glucose level in the context of insulin
resistance and relative insulin deficiency [30]. Although the
distinctive causes and factors of diabetes have not been
clarified, the development of T2DM has been known to be
influenced by genetic and environmental factors. Currently,
many studies are attempting to discover genes causing T2DM,
and remarkable numbers of susceptible genes have been found.
In particular, exponential progress in the development of a
high-density chip platform has led to robust studies with GWAS
analysis, a method that uses a chip with hundreds of thousands
of markers. As a result, genes such as CDKAL1, SLC30A8,
HHEX, EXT2, IGF2BP2, CDKN2B, LOC387761, FTO, KCNQ1,
TCF7L2, and BCL11A have been reported to be susceptible
genes for T2DM [6,31,32]. However, most of the current
research only focuses on SNPs as genetic markers, whereas
T2DM studies using CNV as a newly discovered genetic marker
are relatively rare.
Recently, Craddock et al. reported that the TSPAN8 gene
may be a putatively associated candidate gene in T2DM, using
large samples and a comparative genomic hybridization (CGH)
array (P=3.9E-5) [7]. However, they failed to identify CNVs
that greatly contribute to the risk of T2DM, a conclusion that is
similar to the results in this study. In addition, Shtir et al.
conducted a study on the association between CNVs and T2DM
in 194 Caucasian patients. However, they were able to show few
evidences of such association [33]. Another report, from Jeon et
al., has shown that CNV in the leptin receptor gene is associated
with T2DM [34]. Our study confirmed the existence of CNV in
the leptin receptor gene by examining intensity change on a
50K chip and conducting qPCR on this gene, which could be a
good reference model for future target gene approach studies
Figure 2. Map of identified common copy number variation and T2DM-associated regions. This figure shows common CNVRs (freq..1%,
red-colored rectangle) and highly common CNVRs (freq..5%, blue colored triangle) from CNVs identified in this study. Putative diseases associated
CNVRs are marked by a green-colored triangle. The location of each CNVR was displayed by the Karyoview of Ensembl (http://apr2006.archive.
ensembl.org/Homo_sapiens/karyoview) according to our previous method [41].
doi:10.1371/journal.pone.0019091.g002
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chip (50K), so it would have been hard to discover T2DM-
susceptible genes through GWAS. Instead, we used the
PennCNV software, a widely used technology for CNV research
[12,14,17,25,27,35,36,37,38,39,40,41], with samples that passed
the strict quality control step. To perform an accurate
association analysis, we also utilized signal intensity, allelic
intensity, and population frequency of the B allele for reliable
CNV identification [25], and logistic regression analysis on
common CNVRs was carried out, controlling for age and
gender as covariates.
To identify more reliable CNVs, we used the Illumina
HumanHap300 BeadChip, which contains 317,503 markers. We
found 7,478 individual CNVs, 2,554 CNVRs, and 164 common
CNVRs (frequency.1%) in a Korean population (n=771). We
also compared our results on the individual CNVs with those
found in the DGV database. Our findings revealed that the
CNVs identified in this study were in concordance with the
DGV database at 71.7%, an indication of high-quality CNVs.
The CNVs (28.3%) that did not match the data in the DGV
may have been due to ethnic or chip platform differences. In
addition, results from gene ontology (GO) analysis showed
that CNVs identified in this study were enriched in the pathways
of cell parts, protein binding, developmental processes, biolo-
gical regulations, and cell communication in the GO category
(Table S2).
To assess disease-susceptible loci for risk of T2DM, genome-
wide CNV association analysis using a logistic regression model
was performed. In this study, we found that three new CNVRs
(chr15:45994758–45999227, chr22:20722473–21702142, and
chr18:3559620–3561217) were significantly associated with the
risk of T2DM. In particular, the chr15:45994758–45999227
region showed the strongest association signal that was retained
even after multiple corrections (P
corr=0.01). Interestingly, the
SEMA6D (sema domain, transmembrane domain [TM], cytoplas-
mic domain [semaphoring] 6D) and SLC24A5 (solute carrier
family 24, member 5) genes are located within 200 kb from this
CNVR (Figure S4). Although the association signals for two other
new CNVRs (chr22:20722473–21702142 and chr18:3559620–
3561217) disappeared after multiple corrections (P
corr=0.06 and
P
corr=0.06, respectively), those regions covered nine T2DM
candidate genes including gamma-glutamyltransferase light chain
2( GGTLC2); LOC648691; LOC96610; POM121 membrane
glycoprotein-like 1, pseudogene (POM121L1P); preferentially
expressed antigen in melanoma (PRAME); pre-B lymphocyte 1
(VPREB1); zinc finger protein 280A (ZNF280A); zinc finger protein
280B (ZNF280B); discs, and a large [Drosophila] homolog-
associated protein 1 (DLGAP1). Most of the identified candidate
genes were related to immune responses and transcriptional
regulations, although the molecular function and the relationship
with the onset of T2DM are still unknown. Therefore, further
studies are required to clarify the role of these genes in an
individual’s susceptibility to T2DM.
In conclusion, we found several CNVRs that were significantly
associated with the risk of T2DM in a Korean population.
Although our findings provide preliminary results on the
relationship between CNV and T2DM, future replication analyses
in larger independent cohorts from various ethnic populations,
and functional studies exploring the underlying mechanisms of
association between the susceptible loci discovered in this study
and T2DM, are also necessary. In addition, rare CNVs have been
recently considered as important variations in association analyses
between rare CNV and diseases. Therefore, we suggest that rare
CNVs from family samples or larger-scale samples can provide
more advanced insights into T2DM genetics. We believe that the
findings and methods in this study will serve as important
resources in future human genome research.
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